Medical Condition News

RSS

NSA launches new Faces of Stroke mini-campaign

National Stroke Association has launched a new Faces of Stroke(SM) mini-campaign designed to educate about the connection between stroke and Afib, a type of irregular heartbeat that increases risk of stroke by five times.

6 Sep 2012

Researchers identify HIF2α gene mutation in cancer tumor cells

For the first time, a mutation in HIF2α, a specific group of genes known as transcription factors that is involved in red blood cell production and cell metabolism, has been identified in cancer tumor cells.

6 Sep 2012

Expenditures for treatment of back and neck problems have nearly doubled since late 1990s

Expenditures for treatment of back and neck problems have nearly doubled since the late 1990s—mainly from increased spending for care provided by medical specialists, according to a report in the September 1 issue of Spine.

6 Sep 2012

Congressional champion for brain science research issues statement in response to $30M NFL grant

Congressman Chaka Fattah (D-PA), the Congressional champion for brain science research and author of the Fattah Neuroscience Initiative, issues this statement in response to today's $30 million grant by the National Football League to the Foundation for the National Institutes of Health.

6 Sep 2012

CSHL publishes genome-wide analysis of transcripts produced within human cells

Most people understand genes to be specific segments of DNA that determine traits or diseases that are inherited. Textbooks suggest that genes are copied into RNA molecules, which are then used as templates for making protein - the highly diverse set of molecules that act as building blocks and engines of our cells. The truth, it now appears, is not so simple.

6 Sep 2012

Clinical trial to test combination of two drugs in treating fibromyalgia

A chronic pain condition and numerous gastrointestinal disorders may all be caused by a virus. That's a Tuscaloosa-based surgeon's theory likely headed for a clinical trial early next year and one drawing support from a University of Alabama researcher who studies how viruses replicate.

6 Sep 2012

Workers with job insecurity more likely to report symptoms of anxiety and depression

Workers who perceive their jobs aren't secure are more likely to rate themselves in poor health and have increased symptoms of anxiety and depression, reports the September Journal of Occupational and Environmental Medicine, official publication of the American College of Occupational and Environmental Medicine (ACOEM).

6 Sep 2012

Thomas Jefferson University Hospitals performs 500th Whipple procedure

Thomas Jefferson University Hospital continues to be the leader in the region in fighting the deadliest of cancers—pancreatic cancer. In August, Charles J. Yeo, MD, FACS, the Samuel D. Gross Professor and Chair of Surgery, and a co-director of the Jefferson Pancreas, Biliary and Related Cancer Center, performed his 500th Whipple procedure at Thomas Jefferson University Hospitals, a life-saving surgery for those suffering with the disease.

6 Sep 2012

All kids are susceptible to concussions

The gridiron is back in action. From little leagues to professional teams, football frenzy has begun, and with it, concerns about concussions. But it's not just jarring tackles that can lead to concussions in kids. According to Dr. Ryan Coates, pediatric neurologist at Loyola University Health System, there are many ways kids are exposed to concussion risks.

6 Sep 2012

Exposure to phthalates increases risk of asthma-related airway inflammation in children

Children exposed to diethyl phthalate (DEP) and butylbenzyl phthalate (BBzP)-phthalate chemicals commonly found in personal care and plastic products-have elevated risk of asthma-related airway inflammation, according to researchers at Columbia Center for Children's Environmental Health (CCCEH) at the Mailman School of Public Health.

6 Sep 2012

Prenatal exposure to piperonyl butoxide increases risk of noninfectious cough in children

Children exposed in the womb to the widely used pesticide additive piperonyl butoxide (PBO) have heightened risk of noninfectious cough at ages 5 and 6, according to researchers at the Columbia Center for Children's Environmental Health (CCCEH) at the Mailman School of Public Health and of Columbia University Medical Center.

6 Sep 2012

Janssen, ImmuNext partner to develop novel cancer therapeutics

ImmuNext, Inc., today announced that it has entered into an agreement with Janssen Biotech, Inc., focused on the development of novel therapeutics that modulate the immune system for the treatment of cancer.

6 Sep 2012

UC Davis plans to open West Coast Metabolomics Center

With a $9.3 million startup grant from the National Institutes of Health, the University of California, Davis, has announced plans to open the West Coast Metabolomics Center, a high-tech consortium of research and service laboratories that will help scientists better understand and develop more effective treatments for complex diseases like diabetes, cancer and atherosclerosis.

6 Sep 2012

Sorafenib could be effective against multiple myeloma

Research from Karolinska Institutet in Sweden shows that sorafenib, a drug used for advanced cancer of the kidneys and liver, could also be effective against multiple myeloma. The disease is one of the more common forms of blood cancer and is generally incurable.

6 Sep 2012

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

AMAG Pharmaceuticals, Inc. today announced that the Swiss Agency for Therapeutic Products (Swissmedic) has granted marketing authorization in Switzerland for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney disease.

6 Sep 2012

Merck, Symphogen announce worldwide license agreement for Sym004 to treat cancers

Symphogen A/S, a private biopharmaceutical company developing recombinant antibody mixtures, a class of antibody therapeutics under investigation for the treatment or prophylaxis of serious human diseases such as cancer or infectious and autoimmune diseases, today announced that an exclusive worldwide license agreement was signed with Merck KGaA, Darmstadt, Germany, for Sym004, an investigational antibody mixture targeting the epidermal growth factor receptor (EGFR).

6 Sep 2012

Modus Five launches Sleep Disorder: a Patient Education Multimedia Course

Modus Five has launched a new educational and user-friendly multimedia software program called Sleep Disorder: a Patient Education Multimedia Course. The software program presents helpful information by using rich graphics, interactive content, videos and animations.

6 Sep 2012

Study examines relationship between life events and survival after diagnosis of melanoma

A study that is published in the last issue of Psychotherapy and Psychosomatics examines the relationship between life events and survival after diagnosis of melanoma, a life-threatening cancer of the skin. Negative, undesirable events are important for health outcomes.

6 Sep 2012

SSM Center for Sleep Disorders, NovaSom announce first AccuSom Deliver partnership

NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, announces its first AccuSom Deliver partnership with SSM Center for Sleep Disorders, a service of SSM Health Care - St. Louis, making convenient, efficient Out-of-Center Sleep Testing (OCST) available to patients at seven locations throughout the area beginning October 1, 2012.

6 Sep 2012

Baxter commences anti-MIF antibody Phase I trial in malignant solid tumors

Baxter International Inc. today announced that the company has begun dosing patients with malignant solid tumors in a Phase I clinical trial of a monoclonal antibody, representing the company's efforts to extend its oncology portfolio with advanced biological research and development.

From Baxter International Inc. 6 Sep 2012

Medical Condition News

NSA launches new Faces of Stroke mini-campaign

Researchers identify HIF2α gene mutation in cancer tumor cells

Expenditures for treatment of back and neck problems have nearly doubled since late 1990s

Congressional champion for brain science research issues statement in response to $30M NFL grant

CSHL publishes genome-wide analysis of transcripts produced within human cells

Clinical trial to test combination of two drugs in treating fibromyalgia

Workers with job insecurity more likely to report symptoms of anxiety and depression

Thomas Jefferson University Hospitals performs 500th Whipple procedure

All kids are susceptible to concussions

Exposure to phthalates increases risk of asthma-related airway inflammation in children

Prenatal exposure to piperonyl butoxide increases risk of noninfectious cough in children

Janssen, ImmuNext partner to develop novel cancer therapeutics

UC Davis plans to open West Coast Metabolomics Center

Sorafenib could be effective against multiple myeloma

AMAG receives Swiss marketing authorization for ferumoxytol to treat iron deficiency anemia

Merck, Symphogen announce worldwide license agreement for Sym004 to treat cancers

Modus Five launches Sleep Disorder: a Patient Education Multimedia Course

Study examines relationship between life events and survival after diagnosis of melanoma

SSM Center for Sleep Disorders, NovaSom announce first AccuSom Deliver partnership

Baxter commences anti-MIF antibody Phase I trial in malignant solid tumors

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News